Skip to main content
OpenTrials

Clinical trial condition

IgA Nephropathy

Explore clinical trials studying IgA Nephropathy. Study availability and eligibility vary by location and protocol.

85 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

IgA Nephropathy trial results

Completed

A Study of Probiotics in IgA Nephropathy

NCT06767592

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Leicester General Hospital, University Hospitals of Leicester NHS Trust Leicester, Leicestershire, United Kingdom
View Trial Details
Completed

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease

NCT05083364

Conditions
Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +10 more
Locations
  • Research Site 1 Camperdown, New South Wales, Australia
  • Research Site 3 Concord, New South Wales, Australia
  • Research Site 2 Clayton, Victoria, Australia
  • Research Site 2 Tbilisi, Georgia
View all 16 locations
View Trial Details
Completed

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

NCT04578834

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • AZ Kidney Dise and Hypertension Ctr Glendale, Arizona, United States
  • AKDHC Medical Research ServicesLLC Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Kaiser Permanente San Diego, California, United States
View all 177 locations
View Trial Details
Completed

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

NCT03366337

Conditions
Abnormalities, Multiple, Autoimmune Diseases, Autosomal Dominant Polycystic Kidney, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenician Centers for Research & Innovation (PCRI) Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Denver Nephrology Denver, Colorado, United States
View all 30 locations
View Trial Details
Completed

Rituximab and RASi in Patients with IgAN

NCT04525729

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions